George Garibaldi Selected Research

(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanone

1/2017	Bitopertin in Negative Symptoms of Schizophrenia-Results From the Phase III FlashLyte and DayLyte Studies.
12/2016	Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme.
6/2014	Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

George Garibaldi Research Topics

Disease

4	Schizophrenia (Dementia Praecox) 01/2017 - 06/2014
1	Major Depressive Disorder (Major Depressive Disorders) 10/2014
1	Bipolar Disorder (Manic Depressive Psychosis) 10/2014

Drug/Important Bio-Agent (IBA)

4	Antipsychotic Agents (Antipsychotics)IBA 01/2017 - 06/2014
3	(4- (3- fluoro- 5- trifluoromethylpyridin- 2- yl)piperazin- 1- yl)(5- methanesulfonyl- 2- (2,2,2- trifluoro- 1- methylethoxy)phenyl)methanoneIBA 01/2017 - 06/2014
1	Antidepressive Agents (Antidepressants)IBA 10/2014
1	Paliperidone Palmitate FDA Link 06/2014
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 06/2014
1	Aripiprazole (Abilify)FDA Link 06/2014
1	N- ((3S)- 1- azabicyclo(2.2.2)oct- 3- yl)- 1H- indazole- 3- carboxamide hydrochlorideIBA 06/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 06/2014
1	Risperidone (Risperdal Consta)FDA LinkGeneric 06/2014